Omacetaxine mepesuccinate in the treatment of intractable chronic myeloid leukemia

Yaoyu Chen,1 Shaoguang Li2 1Department of Oncology, Novartis Institutes for Biomedical Research, Cambridge, 2Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA Abstract: In a significant proportion of patients with chronic myeloi...

Full description

Bibliographic Details
Main Authors: Chen Y, Li S
Format: Article
Language:English
Published: Dove Medical Press 2014-01-01
Series:OncoTargets and Therapy
Online Access:http://www.dovepress.com/omacetaxine-mepesuccinate-in-the-treatment-of-intractable-chronic-myel-a15680